Diffusion-weighted imaging in monitoring the pathological response to neoadjuvant chemotherapy in patients with breast cancer: a meta-analysis

BACKGROUND: Diffusion-weighted imaging (DWI) is suggested as an non-invasive and non-radioactive imaging modality in the identification of pathological complete response (pCR) in breast cancer patients receiving neoadjuvant chemotherapy (NACT). A growing number of trials have been investigating in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Wen, Guo, Ning, Dong, Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6052572/
https://www.ncbi.nlm.nih.gov/pubmed/30021656
http://dx.doi.org/10.1186/s12957-018-1438-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6052572/
https://www.ncbi.nlm.nih.gov/pubmed/30021656
http://dx.doi.org/10.1186/s12957-018-1438-y

Ejemplares similares